Prevalence of Reverse Triggering in Early ARDS: Results From a Multicenter Observational Study

Chest. 2021 Jan;159(1):186-195. doi: 10.1016/j.chest.2020.08.018. Epub 2020 Aug 14.

Abstract

Background: The prevalence of reverse triggering (RT) in the early phase of ARDS is unknown.

Research question: During early ARDS, what is the proportion of patients affected by RT, what are its potential predictors, and what is its association with clinical outcomes?

Study design and methods: This was prospective, multicenter, and observational study. Patients who met the Berlin definition of ARDS with less than 72 h of mechanical ventilation and had not been paralyzed with neuromuscular blockers were screened. A 30-min recording of respiratory signals was obtained from the patients as soon as they were enrolled, and the number of breaths with RT were counted.

Results: One hundred patients were included. ARDS was mild to moderate in 92% of them. The recordings were obtained after a median of 1 day (interquartile range, 1-2 days) of ventilation. Fifty patients had RT, and most of these events (97%) were not associated with breath stacking. Detecting RT was associated with lower tidal volume (Vt) and less opiate infusion. The presence of RT was not associated with time to discontinuation of mechanical ventilation (subdistribution hazard ratio, 1.03; 95% CI, 0.6-1.77), but it possibly was associated with a reduced hospital mortality (hazard ratio, 0.65; 95% CI, 0.57-0.73).

Interpretation: Fifty percent of patients receiving assist-control ventilation for mild or moderate ARDS, sedated and nonparalyzed, demonstrate RT without breath stacking on the first day of mechanical ventilation. RT may be associated with low VTS and opiate doses.

Trial registry: ClinicalTrials.gov; No.: NCT02732041; URL: www.clinicaltrials.gov.

Keywords: adult; artificial; hospital mortality; respiration; respiratory distress syndrome.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Aged
  • Female
  • Hospital Mortality
  • Hospitalization
  • Humans
  • Inhalation
  • Male
  • Middle Aged
  • Prevalence
  • Prospective Studies
  • Respiration, Artificial*
  • Respiratory Distress Syndrome / mortality
  • Respiratory Distress Syndrome / physiopathology*
  • Respiratory Distress Syndrome / therapy*
  • Respiratory Rate
  • Tidal Volume

Associated data

  • ClinicalTrials.gov/NCT02732041